Dilated Cardiomyopathy (DCM) is a critical cardiovascular condition marked by the enlargement of the heart's chambers, particularly the left ventricle. This pathology results in the weakening of the heart muscle, compromising its ability to pump blood effectively. The dilation and diminished pumping function characterize the heart's struggle in maintaining its normal operation. Various factors contribute to the development of DCM, such as genetic predisposition, viral infections, certain medications, and exposure to toxins. Recognizable symptoms often encompass fatigue, shortness of breath, leg swelling, and irregular heartbeat. Identification of DCM in its early stages is crucial for effectively managing the condition and preventing potential complications. Diagnostic measures typically involve a combination of medical history assessments, physical examinations, and advanced cardiac imaging techniques. Treatment strategies for DCM are multifaceted and may involve medications to enhance heart function, mitigate symptoms, and manage underlying causes.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation